Phase 3 ST Elevation Myocardial Infarction Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
STEMI - ST Elevation Myocardial Infarction
Thomas Engstrom5,204 enrolled4 locationsNCT07478003
Recruiting
Phase 3
Dapagliflozin in STEMI
Myocardial InfarctionST Elevation Myocardial Infarction
Ottawa Heart Institute Research Corporation256 enrolled1 locationNCT06174753
Recruiting
Phase 3
Epicardial Cardiac Fat-CT (EPIC-CT)
STEMI - ST Elevation Myocardial Infarction
Instituto Mexicano del Seguro Social136 enrolled1 locationNCT07297589
Withdrawn
Phase 3
Does flow measurement guided stenting of non-culprit lesions as compared with visual assessment guided stenting in patients presenting with a heart attack improve outcomes.
and non-ST elevation myocardial infarction (non-STEMI)
Professor Harvey White850 enrolled1 locationACTRN12615000321549
Completed
Phase 3Phase 4
The NACIAM Study – Assessing the benefit of N-Acetylcysteine (NAC) in acute heart attacks.
Acute ST Elevation Myocardial Infarction requiring urgent revascularisation (angioplsty or stent). The ST segment refers to that of QRST complex as represented on a 12 lead ECG (Electrocardiograph).
The Queen Elizabeth Hospital Cardiology Unit80 enrolled1 locationACTRN12610000280000